Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

ClinicalTrials.gov ID: NCT04065841

Public ClinicalTrials.gov record NCT04065841. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel-group, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Oral Tropifexor (LJN452) & Licogliflozin (LIK066) Combination Therapy and Each Monotherapy, Compared With Placebo for Treatment of Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis.(ELIVATE)

Study identification

NCT ID
NCT04065841
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
234 participants

Conditions and interventions

Interventions

  • Tropifexor Drug
  • Licogliflozin Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 29, 2019
Primary completion
Oct 26, 2022
Completion
Oct 26, 2022
Last update posted
Jan 27, 2025

2019 – 2022

United States locations

U.S. sites
28
U.S. states
13
U.S. cities
26
Facility City State ZIP Site status
Gut PC Digestive Health Specialist Dothan Alabama 36305
Southern California Research Center Coronado California 92118
Velocity Clinical Trials Los Angeles California 90057
California Liver Research Institute Pasadena California 91105
Medical Associates Research Group San Diego California 92123
San fernando Valley Health Institute Van Nuys California 91405
Island View Gastroenterology Associates Ventura California 93003
Integrity Clinical Rsh LLC Doral Florida 33166
Galenus Group Lehigh Acres Florida 33936
Genoma Research Group Inc Miami Florida 33165-7574
Digestive Res Alliance of Michiana South Bend Indiana 46635
Southern Therapy and Adv Res LLC Jackson Mississippi 39216
Clinical Research Professionals Inc Chesterfield Missouri 63005
Southwest Gastroenterology Associates Albuquerque New Mexico 87109
Northwell Health Manhasset New York 11030
Clinical Trials Of America LLC Lenoir North Carolina 28645
Diabetes And Endocrinology Conslt Morehead City North Carolina 28557
Options Health Research Tulsa Oklahoma 74104
Prisma Health Greenville South Carolina 29605
Digestive Disease Research Greenwood South Carolina 29646
Palmetto Clinical Research Summerville South Carolina 29485
Summit Medical Care Hermitage Tennessee 37076
Texas Clinical Research Institute Arlington Texas 76012
Dallas Diabetes and Endocrine Center Dallas Texas 75230
American Research Corporation at Texas Liver Institute San Antonio Texas 78215
Clinical Trials of Texas San Antonio Texas 78229
Endeavor Clinical Trials San Antonio Texas 78240
Pioneer Research Solutions Sugar Land Texas 77479

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04065841, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04065841 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →